-
Modulating IL-21-driven B cell responses in idiopathic inflammatory myopathies via inhibition of the JAK/STAT pathway
Merino-Vico, A., Kocyigit, M., Frazzei, G., Landman, L., Boon, L., van Leeuwen, E. M., Lundberg, I. E., van der Kooi, A. J., Raaphorst, J., van Hamburg, J. P. & Tas, S. W., 1 Dec 2025, In: Arthritis Research and Therapy. 27, 1, 76.Research output: Contribution to journal › Article › Academic › peer-review
-
Emerging therapies in idiopathic inflammatory myopathies
Kocyigit, M., van Hamburg, J. P., Aronica, E., van der Kooi, A. J., Tas, S. W. & Raaphorst, J., 23 Oct 2025, (E-pub ahead of print) In: Journal of Neuromuscular Diseases. p. 22143602251384098Research output: Contribution to journal › Review article › Academic › peer-review
-
Ocrelizumab concentration and antidrug antibodies are associated with B-cell count in multiple sclerosis
Toorop, A. A., Hogenboom, L., Bloem, K., Kocyigit, M., Commandeur, N. W. M., Wijnants, A., Lissenberg-Witte, B. I., Strijbis, E. M. M., Uitdehaag, B. M. J., Rispens, T., Killestein, J. & van Kempen, Z. L. E., 1 Jun 2023, In: Journal of Neurology, Neurosurgery and Psychiatry. 94, 6, p. 487-493 7 p., jnnp-2022-330793.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
